Regenerative treatment for mandibular molar furcation defects using xenograft with enamel matrix derivative
Official title: Efficacy of Enamel Matrix Derivative Combined With Xenograft in the Treatment of Furcation Defects in Mandibular Molars
Run by University of Medicine and Pharmacy at Ho Chi Minh City · NCT07776756 · Data updated 2026-11-12
This randomized trial tests two regenerative approaches for mandibular molar Class II furcation defects in people with periodontitis to see which method improves healing and patient comfort.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | University of Medicine and Pharmacy at Ho Chi Minh City Academic / other |
| Locations | 1 site (Ho Chi Minh City, Binh Phu) |
| Status | Recruiting |
| Started | June 29, 2026 |
| Main results expected | September 29, 2027 |
| Study ends | September 30, 2027 |
| Registry record updated | August 20, 2026 |
| Trial ID | NCT07776756 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18+ with mandibular first/second molar Class II furcation defects (A2/B2) and suitable oral health indicators, willing to consent.
✕Probably not a fit
Patients with systemic conditions affecting healing or non-qualifying furcation defects may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial compares two regenerative surgical approaches for mandibular molar Class II furcation defects in adults with periodontitis. One group receives xenograft bone plus enamel matrix derivative (EMD); the other group receives xenograft bone plus a collagen membrane. Participants will be followed for about seven months to assess clinical parameters, imaging changes, and patient-reported outcomes such as pain and satisfaction. Before and after surgery, measurements include plaque and bleeding indices, pocket depth, attachment loss, and furcation defect volume and bone density by CBCT, with GCF TWEAK levels explored. The study plans 24 teeth from eligible participants, with random assignment to the two treatments and follow-ups at 2 weeks, 1 month, 3 months, and 6 months.
Why it matters
Potential benefit: If successful, the EMD-containing approach could improve periodontal regeneration and patient-centered outcomes for challenging furcation defects.
How similar studies have gone: Prior studies suggest regenerative techniques can improve outcomes in furcation defects, but results vary by materials used; this trial evaluates two common regenerative approaches.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years or older. * Full-mouth plaque score (FMPS) ≤ 20%. * Full-mouth bleeding score (FMBS) ≤ 20%. * Willingness to participate in the study and provide informed consent. * Mandibular first and/or second molar with a buccal Class II furcation defect classified as subgroup A2 or B2. * Probing pocket depth (PPD) ≥ 5 mm at the eligible furcation site. * Keratinized gingival height ≥ 2 mm at the eligible site. * No gingival recession extending apically beyond the buccal furcation roof; the furcation entrance must not be clinically exposed above the gingival margin. Exclusion Criteria: * Systemic diseases or conditions that may affect periodontal treatment outcomes, including uncontrolled diabetes mellitus, heart disease requiring anticoagulant therapy, hematologic disorders, or immunodeficiency. * Pregnancy or breastfeeding. * Untreated endodontic pathology involving the study tooth. * Class III furcation involvement according to the Hamp classification. * Untreated occlusal trauma involving the study tooth. * Grade II tooth mobility that has not been stabilized by splinting, or Grade III tooth mobility according to the Miller classification. * Defective restorations at the surgical site, including overhanging, bulky, or poorly adapted restorations.
Where it's running
-
Faculty of Dentistry, University of Medicine and Pharmacy at Ho Chi Minh City
Ho Chi Minh City, Binh Phu, Vietnam Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Minimally invasive treatment with i-PRF and xenograft for Class II furcation defects in mandibular molars
This study tests whether using injectable platelet-rich fibrin (i-PRF) with or without a xenograft can improve healing for Class II furcation defects in lower molars after periodontal therapy.
-
Health education program to help depression in older adults and caregivers in Ho Chi Minh City
A community-based education program for people 60+ and their caregivers is being tested to see if it can lower depression and improve quality of life compared with standard care.
-
Mandibular molar furcation defects in advanced periodontitis: a regenerative treatment comparison
In people with advanced gum disease, this study tests two regenerative treatments for Hamp Class II furcation defects in lower molars to see which works better and whether CBCT imaging matches what clinicians find during surgery.
-
A-PRF+ with Xenograft vs Collagen Membrane with Xenograft for Degree II Furcation Defects in Mandibular Molars
This trial tests whether using advanced platelet-rich fibrin with a xenograft works better than a collagen membrane with a xenograft to treat degree II furcation defects in lower first molars of adults with periodontitis.
-
Home-use dual-light antibacterial therapy for peri-implant mucositis around full-arch implants
This study tests whether a home-use dual-light device added to standard care can better control gum inflammation around full-arch dental implants than standard care alone.
-
FARES vs. traction-countertraction for acute anterior shoulder dislocation
This trial tests whether the FARES technique can reduce an acute anterior shoulder dislocation faster and with less pain than the traditional traction-countertraction method in adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.